PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F16EW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $35,140
Award facts
- Contract value 100% obligated
- $35,140.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,140.35 by the Defense Logistics Agency (DLA) Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price delivery order is a competitive award with no set-aside designation and represents work performed at the contractor's Conshohocken facility. The award is issued under the contractor's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which also maintains a significant $999,999,999.00 IDC with DLA Troop Support Medical extending through December 31, 2031. The contractor's federal contracting activity demonstrates extensive capability in fulfilling government medical procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This delivery order exemplifies the company's role as a critical vendor for federal military and veteran healthcare systems, leveraging its position under DLA's Pharmaceutical Prime Vendor program to provide essential pharmaceutical commodities to government healthcare institutions.
Quick answers
Who was awarded contract SPE2D826F16EW?
SPE2D826F16EW was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on February 2, 2026.
How much is contract SPE2D826F16EW worth?
The government has obligated $35,140 on SPE2D826F16EW.
Is contract SPE2D826F16EW an order under another contract?
Yes. SPE2D826F16EW is a delivery order under SPE2DX22D0029, an indefinite delivery contract.
Was contract SPE2D826F16EW competed?
The extent of competition for SPE2D826F16EW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award